Analysts expect Nu Skin Enterprises, Inc. (NYSE:NUS) to report quarterly sales of $610.69 million


The brokerages expect Nu Skin Enterprises, Inc. (NYSE: NUS – Get Rating) to report revenue of $610.69 million for the current quarter, reports Zacks Investment Research. Two analysts released earnings estimates for Nu Skin Enterprises, with the lowest sales estimate of $606.50 million and the highest estimate of $614.87 million. Nu Skin Enterprises recorded sales of $704.06 million in the same quarter last year, indicating a negative growth rate of 13.3% year-over-year. The company is expected to release its next earnings report on Monday, January 1.

On average, analysts expect Nu Skin Enterprises to report annual sales of $2.56 billion in the current fiscal year, with estimates ranging from $2.55 billion to $2.58 billion. For next year, analysts expect the company to post sales of $2.62 billion, with estimates ranging from $2.59 billion to $2.66 billion. Zacks Investment Research sales calculations are an average based on a survey of research analysts who cover Nu Skin Enterprises.

Nu Skin Enterprises (NYSE:NUS – Get Rating) last reported quarterly earnings data on Wednesday, May 4. The company reported earnings per share (EPS) of $0.76 for the quarter, beating consensus analyst estimates of $0.72 by $0.04. Nu Skin Enterprises achieved a net margin of 5.28% and a return on equity of 22.05%. The company posted revenue of $604.90 million for the quarter, compared to $579.70 million expected by analysts. During the same period last year, the company earned earnings per share of $0.91. The company’s revenue for the quarter was down 10.7% year over year.

A number of brokerages have published reports on NUS. Zacks Investment Research moved Nu Skin Enterprises shares from a “hold” rating to a “strong-buy” rating and set a price target of $57.00 on the stock in a Tuesday research note March 29. StockNews.com downgraded Nu Skin Enterprises shares from a “buy” rating to a “hold” rating in a report on Friday. Jefferies Financial Group raised its target price on Nu Skin Enterprises shares from $61.00 to $75.00 in a Thursday, February 17 report. TheStreet downgraded shares of Nu Skin Enterprises from a “b” rating to a “c+” rating in a Friday, February 18 report. Finally, DA Davidson raised his price target on Nu Skin Enterprises stock from $47.00 to $50.00 and gave the stock a “neutral” rating in a Thursday, February 17 report. Three analysts gave the stock a hold rating, one gave the company a buy rating and one gave the company a high buy rating. According to MarketBeat.com, Nu Skin Enterprises currently has a consensus rating of “Buy” and a consensus price target of $60.60.

Shares of NUS opened at $46.48 on Friday. Nu Skin Enterprises has a 52 week minimum of $39.40 and a 52 week maximum of $62.70. The stock has a market capitalization of $2.32 billion, a PE ratio of 17.21 and a beta of 1.24. The company has a debt ratio of 0.28, a quick ratio of 0.95 and a current ratio of 1.72. The company’s 50-day moving average price is $46.72 and its two-hundred-day moving average price is $47.83.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 8. Investors of record on Friday, May 27 will receive a dividend of $0.385 per share. The ex-dividend date is Thursday, May 26. This represents a dividend of $1.54 on an annualized basis and a dividend yield of 3.31%. Nu Skin Enterprises payout ratio is 57.04%.

Separately, CEO Ryan S. Napierski sold 25,000 shares of the company in a trade on Friday, February 25. The shares were sold at an average price of $47.40, for a total value of $1,185,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, accessible via the SEC’s website. Additionally, director Andrew D. Lipman sold 1,000 shares of the company in a trade on Tuesday, February 22. The shares were sold at an average price of $53.27, for a total transaction of $53,270.00. The disclosure of this sale can be found here. In the past 90 days, insiders have sold 28,000 shares of the company worth $1,333,390. 2.80% of the shares are currently held by insiders of the company.

A number of institutional investors have recently increased or reduced their stake in NUS. TCI Wealth Advisors Inc. increased its position in Nu Skin Enterprises by 66.6% in the fourth quarter. TCI Wealth Advisors Inc. now owns 758 shares of the company valued at $38,000 after buying 303 additional shares in the last quarter. Covestor Ltd bought a new position in Nu Skin Enterprises in the fourth quarter worth $48,000. Quadrant Capital Group LLC increased its position in Nu Skin Enterprises by 47.1% in the fourth quarter. Quadrant Capital Group LLC now owns 1,068 shares of the company valued at $54,000 after buying 342 additional shares in the last quarter. JJJ Advisors Inc. increased its position in Nu Skin Enterprises by 216.9% in the fourth quarter. JJJ Advisors Inc. now owns 1,870 shares of the company valued at $95,000 after purchasing an additional 1,280 shares in the last quarter. Finally, Gladius Capital Management LP bought a new position in Nu Skin Enterprises in the fourth quarter worth $98,000. 93.79% of the shares are held by institutional investors and hedge funds.

Nu Skin Enterprises Company Profile (Get an evaluation)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems and ageLOC LumiSpa skin cleansing and treatment devices; and ageLOC Boost, plus a range of other cosmetic and personal care products.

Featured articles

Get a Free Copy of Zacks’ Research Report on Nu Skin Enterprises (NUS)

For more information on Zacks Investment Research’s research offerings, visit Zacks.com

Earnings history and estimates for Nu Skin Enterprises (NYSE: NUS)



Receive daily news and reviews for Nu Skin Enterprises – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Nu Skin Enterprises and related companies with MarketBeat.com’s free daily email newsletter.